Expression of Concern: Insulin Sensitiser Agents Alone and in Co-Treatment with r-FSH for Ovulation Induction in PCOS Women

doi:10.1080/09513590.2026.2687275

June 16, 2026Gynecological EndocrinologyOpen Access

Expression of Concern: Insulin Sensitiser Agents Alone and in Co-Treatment with r-FSH for Ovulation Induction in PCOS Women

View Full Paper

Ask AI

Bookmark

Share

Key Points

To address concerns regarding the use of insulin sensitising agents with r-FSH for ovulation induction in women with PCOS.
Evaluation of existing literature regarding insulin sensitiser agents and r-FSH treatment.
Assessment of treatment effects and outcomes in context of PCOS.
Concerns raised regarding the efficacy of insulin sensitiser agents alone and in combination with r-FSH for ovulation induction.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Expression of concern addresses insulin sensitiser agents and their use with r-FSH for ovulation induction in women with PCOS, highlighting potential issues.

Abstract

We, the Editor and Publisher of Gynecological Endocrinology, are issuing an Expression of Concern for the following article:Raffone, E., Rizzo, P., & Benedetto, V. (2010). Insulin sensitiser agents...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

A 2026 study studied this question.

synapsesocial.com/papers/6a34de7065a5b0777af2dca1 https://doi.org/10.1080/09513590.2026.2687275

View Full Paper

Ask AI

Bookmark

Share

Expression of Concern: Insulin Sensitiser Agents Alone and in Co-Treatment with r-FSH for Ovulation Induction in PCOS Women

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Expression of Concern: Insulin Sensitiser Agents Alone and in Co-Treatment with r-FSH for Ovulation Induction in PCOS Women

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading